Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer

NCT02758652 is registered in ClinicalTrials.gov with Tampere University Hospital as lead sponsor.

NCT NCT02758652
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02758652 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian Cancer
Lead sponsor
Tampere University Hospital
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2016
Completion date
May 31, 2026
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer